Cargando…
Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition
P-glycoprotein (P-gp, ABCB1) over-expression, causing a multi-drug resistant (MDR) phenotype, is a major problem in cancer chemotherapy that urgently requires novel approaches. Our previous studies showed certain ecdysteroid derivatives as promising chemo-sensitizers against MDR and non-MDR cancer c...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155823/ https://www.ncbi.nlm.nih.gov/pubmed/28125071 http://dx.doi.org/10.3390/molecules22020199 |
_version_ | 1783357974275686400 |
---|---|
author | Hunyadi, Attila Csábi, József Martins, Ana Molnár, Joseph Balázs, Attila Tóth, Gábor |
author_facet | Hunyadi, Attila Csábi, József Martins, Ana Molnár, Joseph Balázs, Attila Tóth, Gábor |
author_sort | Hunyadi, Attila |
collection | PubMed |
description | P-glycoprotein (P-gp, ABCB1) over-expression, causing a multi-drug resistant (MDR) phenotype, is a major problem in cancer chemotherapy that urgently requires novel approaches. Our previous studies showed certain ecdysteroid derivatives as promising chemo-sensitizers against MDR and non-MDR cancer cell lines while also exerting mild to moderate inhibition of P-gp function. Here we report the preparation of a set of substituted 2,3-dioxolane derivatives of poststerone, a known in vivo metabolite of 20-hydroxyecdysone (20E). In contrast with previously studied ecdysteroid dioxolanes, the majority of the new compounds did not inhibit the efflux function of P-gp. Nevertheless, a strong, dose dependent sensitization to doxorubicin was observed on a P-gp transfected cancer cell line and on its susceptible counterpart. We also observed that the MDR cell line was more sensitive to the compounds’ effect than the non-MDR. Our results showed for the first time that the chemo-sensitizing activity of ecdysteroids can be fully independent of functional efflux pump inhibition, and suggest these compounds as favorable leads against MDR cancer. |
format | Online Article Text |
id | pubmed-6155823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61558232018-11-13 Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition Hunyadi, Attila Csábi, József Martins, Ana Molnár, Joseph Balázs, Attila Tóth, Gábor Molecules Article P-glycoprotein (P-gp, ABCB1) over-expression, causing a multi-drug resistant (MDR) phenotype, is a major problem in cancer chemotherapy that urgently requires novel approaches. Our previous studies showed certain ecdysteroid derivatives as promising chemo-sensitizers against MDR and non-MDR cancer cell lines while also exerting mild to moderate inhibition of P-gp function. Here we report the preparation of a set of substituted 2,3-dioxolane derivatives of poststerone, a known in vivo metabolite of 20-hydroxyecdysone (20E). In contrast with previously studied ecdysteroid dioxolanes, the majority of the new compounds did not inhibit the efflux function of P-gp. Nevertheless, a strong, dose dependent sensitization to doxorubicin was observed on a P-gp transfected cancer cell line and on its susceptible counterpart. We also observed that the MDR cell line was more sensitive to the compounds’ effect than the non-MDR. Our results showed for the first time that the chemo-sensitizing activity of ecdysteroids can be fully independent of functional efflux pump inhibition, and suggest these compounds as favorable leads against MDR cancer. MDPI 2017-01-25 /pmc/articles/PMC6155823/ /pubmed/28125071 http://dx.doi.org/10.3390/molecules22020199 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hunyadi, Attila Csábi, József Martins, Ana Molnár, Joseph Balázs, Attila Tóth, Gábor Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition |
title | Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition |
title_full | Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition |
title_fullStr | Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition |
title_full_unstemmed | Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition |
title_short | Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition |
title_sort | backstabbing p-gp: side-chain cleaved ecdysteroid 2,3-dioxolanes hyper-sensitize mdr cancer cells to doxorubicin without efflux inhibition |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155823/ https://www.ncbi.nlm.nih.gov/pubmed/28125071 http://dx.doi.org/10.3390/molecules22020199 |
work_keys_str_mv | AT hunyadiattila backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition AT csabijozsef backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition AT martinsana backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition AT molnarjoseph backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition AT balazsattila backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition AT tothgabor backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition |